Tabula Rasa HealthCare (TRHC) Stock Price
Tabula Rasa HealthCare Price
Revenue has compounded at 31.7% per year over the past 9 years to 299.52 M USD. Tabula Rasa HealthCare's net margin stands at -25.8%, down from -23.1% several years earlier.
Tabula Rasa HealthCare stock price
Tabula Rasa HealthCare business model & stock analysis
Frequently asked questions about Tabula Rasa HealthCare
Tabula Rasa HealthCare Inc is a healthcare technology company that offers personalized medication safety solutions. Their business model involves developing and deploying technology solutions to enhance patient care and optimize medication management. By leveraging data analytics and proprietary systems, Tabula Rasa provides healthcare organizations with tools to identify and mitigate medication risks, improve patient outcomes, and reduce costs. Through their software platforms, such as MedWise and CareKinesis, Tabula Rasa helps healthcare providers optimize medication regimens and address medication-related challenges. By providing tailored solutions, Tabula Rasa HealthCare Inc aims to enhance medication safety for patients and improve overall healthcare quality.
Tabula Rasa HealthCare Inc is primarily active in the healthcare industry.
The main competitors of Tabula Rasa HealthCare Inc in the market include OptumRx, Cerner Corporation, and McKesson Corporation.
Tabula Rasa HealthCare Inc. is a prominent healthcare technology company with a rich history and background. Founded in 2009, Tabula Rasa HealthCare Inc. specializes in providing innovative solutions for personalized medication management. Through its advanced software platforms and clinical decision support tools, the company aims to improve patient care and reduce healthcare costs. Tabula Rasa HealthCare Inc. offers a wide range of services, including medication risk mitigation, pharmacogenomic testing, and electronic health record integration. With a focus on enhancing patient safety and outcomes, Tabula Rasa HealthCare Inc. has become a trusted name in the healthcare industry, providing cutting-edge solutions for healthcare providers and systems.
Some significant milestones achieved by Tabula Rasa HealthCare Inc include its successful IPO in 2014, being listed on the NASDAQ stock exchange, and consistently delivering strong financial performance. The company has experienced rapid growth and expansion, with acquisitions of Mediture and CareKinesis, further enhancing their offering in personalized medication management services. Tabula Rasa HealthCare Inc has also received several prestigious awards and recognitions, including being named one of the fastest-growing companies by Inc. 5000. These achievements highlight the company's commitment to innovation, strategic acquisitions, and driving positive patient outcomes in the healthcare industry.
Tabula Rasa HealthCare Inc is primarily present in the United States.
Tabula Rasa HealthCare Inc is guided by its core values of integrity, innovation, and collaboration. With a strong corporate philosophy focused on improving healthcare outcomes, Tabula Rasa HealthCare Inc is dedicated to providing personalized medication risk mitigation solutions. The company's mission is to optimize medication regimens for individuals, ensuring safer and more effective healthcare practices. Tabula Rasa HealthCare Inc's commitment to innovation and collaboration helps them drive positive change in the healthcare industry, ultimately benefiting patients and providers. By staying true to its values and corporate philosophy, Tabula Rasa HealthCare Inc aims to revolutionize medication safety and improve patient well-being.
9 analysts currently rate the Tabula Rasa HealthCare stock: 0 recommend buying, 6 holding and 3 selling.
The Tabula Rasa HealthCare share (TRHC) is listed on 3 stock exchanges, including: NASDAQ (TRHC), Frankfurt (43T.F), München (43T.MU).
Tabula Rasa HealthCare Inc. (TRHC) is a US company that offers health IT solutions and supports its customers in promoting medication therapy safety. The company provides services in three divisions: Medication Risk Mitigation, Pharmacy Services, and CareVention HealthCare.
The revenue cannot currently be calculated for Tabula Rasa HealthCare.
The profit cannot currently be calculated for Tabula Rasa HealthCare.
The P/E ratio cannot be calculated for Tabula Rasa HealthCare at the moment.
The P/S cannot be calculated for Tabula Rasa HealthCare currently.
The Eulerpool Quality Score for Tabula Rasa HealthCare is 1/10.
The ISIN of Tabula Rasa HealthCare is US8733791011. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Tabula Rasa HealthCare is A2ASWL. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Tabula Rasa HealthCare is TRHC. The ticker symbol is used to trade Tabula Rasa HealthCare shares on the stock exchange.
Tabula Rasa HealthCare stock
Tabula Rasa HealthCare Peer Group
Tabula Rasa HealthCare Ticker
Tabula Rasa HealthCare FIGI
All fundamentals and in-depth analysis of Tabula Rasa HealthCare
Our stock analysis for Tabula Rasa HealthCare stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Tabula Rasa HealthCare. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.